应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CPRX Catalyst Pharmaceutical Partners
耶稣受难日休市 03-28 16:00:00 EDT
15.94
-0.33
-2.03%
盘后
15.90
-0.04
-0.25%
19:42 EDT
最高
16.50
最低
15.78
成交量
117.24万
今开
16.29
昨收
16.27
日振幅
4.46%
总市值
18.79亿
流通市值
16.16亿
总股本
1.18亿
成交额
1,876万
换手率
1.16%
流通股本
1.01亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Catalyst Pharmaceuticals, Inc.盘中异动 大幅拉升5.02%
自选股智能写手 · 03-28 00:04
Catalyst Pharmaceuticals, Inc.盘中异动 大幅拉升5.02%
Catalyst Pharmaceuticals, Inc.2023财年实现净利润71.41百万美元,同比减少14.05%
自选股智能写手 · 03-04
Catalyst Pharmaceuticals, Inc.2023财年实现净利润71.41百万美元,同比减少14.05%
Catalyst Pharmaceuticals, Inc.股价拉升11.61% 市值涨2.25亿美元
自选股智能写手 · 02-29
Catalyst Pharmaceuticals, Inc.股价拉升11.61% 市值涨2.25亿美元
嗡嗡声--美国股票走势-Voyager Therapeutics、GoodRx Holdings、Tenet Healthcare
Reuters · 02-29
嗡嗡声--美国股票走势-Voyager Therapeutics、GoodRx Holdings、Tenet Healthcare
Catalyst Pharmaceuticals Inc 预计每股收益 27 美分 - 财报前瞻
Reuters · 02-27
Catalyst Pharmaceuticals Inc 预计每股收益 27 美分 - 财报前瞻
Catalyst Pharmaceuticals Inc2023财年第三财季实现净利润-30.76百万美元,同比减少235.21%
自选股智能写手 · 2023-11-18
Catalyst Pharmaceuticals Inc2023财年第三财季实现净利润-30.76百万美元,同比减少235.21%
Catalyst Pharmaceuticals Inc盘中异动 早盘股价大跌5.06%报12.76美元
自选股智能写手 · 2023-10-27
Catalyst Pharmaceuticals Inc盘中异动 早盘股价大跌5.06%报12.76美元
加载更多
公司概况
公司名称:
Catalyst Pharmaceutical Partners
所属市场:
NASDAQ
上市日期:
--
主营业务:
Catalyst Pharmaceuticals, Inc.于2006年7月在特拉华州注册成立。该公司是一家商业阶段、以患者为中心的生物制药公司,专注于为患有罕见和难以治疗的疾病的患者提供新的高质量药物的许可、开发和商业化。该公司利用协调一致的勤奋努力,寻找能够改善那些患有罕见或难以治疗的疾病的人的生活的疗法。
发行价格:
--
{"stockData":{"symbol":"CPRX","market":"US","secType":"STK","nameCN":"Catalyst Pharmaceutical Partners","latestPrice":15.94,"timestamp":1711656000000,"preClose":16.27,"halted":0,"volume":1172375,"hourTrading":{"tag":"盘后","latestPrice":15.9,"preClose":15.94,"latestTime":"19:42 EDT","volume":49888,"amount":795247.0584,"timestamp":1711669379035},"delay":0,"floatShares":101356178,"shares":117863258,"eps":0.629999,"marketStatus":"耶稣受难日休市","marketStatusCode":7,"change":-0.33,"latestTime":"03-28 16:00:00 EDT","open":16.29,"high":16.5,"low":15.775,"amount":18762581.6415,"amplitude":0.044561,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.629999,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1711958400000},"adr":0,"listingDate":1162962000000,"adjPreClose":16.27,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":16.41,"preClose":16.27,"latestTime":"09:20 EDT","volume":5678,"amount":93879.34225,"timestamp":1711632010746},"postHourTrading":{"tag":"盘后","latestPrice":15.9,"preClose":15.94,"latestTime":"19:42 EDT","volume":49888,"amount":795247.0584,"timestamp":1711669379035},"volumeRatio":0.9450929645790086},"requestUrl":"/m/hq/s/CPRX","defaultTab":"news","newsList":[{"id":"2422483959","title":"Catalyst Pharmaceuticals, Inc.盘中异动 大幅拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422483959","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422483959?lang=zh_cn&edition=full","pubTime":"2024-03-28 00:04","pubTimestamp":1711555442,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日00时04分,Catalyst Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.02%。Catalyst Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.19%。其相关个股中,Ibio, Inc.、Moolec Science Sa C/Wts 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃,换手率分别为3178.86%、1187.69%、70.06%,振幅较大的相关个股有Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Stoke Therapeutics, Inc.,振幅分别为86.96%、78.00%、58.70%。Catalyst Pharmaceuticals, Inc.公司简介:Catalyst Pharmaceuticals Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328000403861e1b96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328000403861e1b96&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416152909","title":"Catalyst Pharmaceuticals, Inc.2023财年实现净利润71.41百万美元,同比减少14.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416152909","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416152909?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:24","pubTimestamp":1709483043,"startTime":"0","endTime":"0","summary":"12月31日,Catalyst Pharmaceuticals, Inc.公布财报,公告显示公司2023财年净利润为71.41百万美元,同比减少14.05%;其中营业收入为3.98亿美元,同比增加85.98%,每股基本收益为0.67美元。从资产负债表来看,Catalyst Pharmaceuticals, Inc.总负债84.03百万美元,其中短期债务369000.00美元,资产负债比为0.06,流动比率为0.03。机构评级:截至2023年12月31日,当前有5家机构对Catalyst Pharmaceuticals, Inc.目标价做出预测,其中目标均价为27.80美元,其中最低目标价为24.00美元,最高目标价为34.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040024088afdd7ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040024088afdd7ea&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415528927","title":"Catalyst Pharmaceuticals, Inc.股价拉升11.61% 市值涨2.25亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415528927","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415528927?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:32","pubTimestamp":1709217131,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时32分,Catalyst Pharmaceuticals, Inc.股票出现波动,股价急速拉升11.61%。截至发稿,该股报16.25美元/股,成交量28.9682万股,换手率0.24%,振幅4.95%。Catalyst Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.31%。其相关个股中,Enveric Biosciences, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Avidity Biosciences, Inc.涨幅较大,Enveric Biosciences, Inc.、Scisparc Ltd.、Neurobo Pharmaceuticals, Inc.较为活跃,换手率分别为1713.91%、52.53%、49.56%,振幅较大的相关个股有Enveric Biosciences, Inc.、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Atara Biotherapeutics, Inc.,振幅分别为33.69%、15.55%、15.35%。Catalyst Pharmaceuticals, Inc.公司简介:Catalyst Pharmaceuticals Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922321187d23ef0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922321187d23ef0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415547381","title":"嗡嗡声--美国股票走势-Voyager Therapeutics、GoodRx Holdings、Tenet Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2415547381","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2415547381?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:20","pubTimestamp":1709216448,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 2月29日 - 华尔街主要股指周四将高开,因为一项关键的通胀指标符合预期,从而提高了美国联邦储备委员会在今年上半年降息的希望。美东时间9:04,道指电子盘 上涨0.22%,报39,079点。标准普尔500指数小型股 上涨0.32%,报5097.25点;纳斯达克100指数小型股 上涨0.57%,报18016.75点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414868514","title":"Catalyst Pharmaceuticals Inc 预计每股收益 27 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414868514","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414868514?lang=zh_cn&edition=full","pubTime":"2024-02-27 05:40","pubTimestamp":1708983624,"startTime":"0","endTime":"0","summary":" * Catalyst Pharmaceuticals Inc 将于2月28日公布截至2023年12月31日的财报,预计该公司的季度收入将有所增长。 * LSEG 分析师对 Catalyst Pharmaceuticals Inc 的平均预期为每股收益 27 美分。* 华尔街对 Catalyst Pharmaceuticals Inc 的 12 个月目标价中位数为 25.00 美元,高于其最新收盘价 14.04 美元。2月26日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2384365028","title":"Catalyst Pharmaceuticals Inc2023财年第三财季实现净利润-30.76百万美元,同比减少235.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2384365028","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2384365028?lang=zh_cn&edition=full","pubTime":"2023-11-18 00:09","pubTimestamp":1700237348,"startTime":"0","endTime":"0","summary":"9月30日,Catalyst Pharmaceuticals Inc公布财报,公告显示公司2023财年第三财季净利润为-30.76百万美元,同比减少235.21%;其中营业收入为1.03亿美元,同比增加79.94%,每股基本收益为-0.29美元。机构评级:截至2023年9月30日,当前有5家机构对Catalyst Pharmaceuticals Inc目标价做出预测,其中目标均价为23.30美元,其中最低目标价为15.50美元,最高目标价为27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023111800091682826a40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023111800091682826a40&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2378805069","title":"Catalyst Pharmaceuticals Inc盘中异动 早盘股价大跌5.06%报12.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2378805069","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2378805069?lang=zh_cn&edition=full","pubTime":"2023-10-27 21:42","pubTimestamp":1698414122,"startTime":"0","endTime":"0","summary":"北京时间2023年10月27日21时42分,Catalyst Pharmaceuticals Inc股票出现波动,股价快速下挫5.06%。截至发稿,该股报12.76美元/股,成交量17.0781万股,换手率0.16%,振幅4.69%。Catalyst Pharmaceuticals Inc股票所在的生物技术行业中,整体跌幅为0.68%。其相关个股中,Apollomics Inc C/Wts 01/04/2028 、Eqrx Inc C/Wts 17/12/2026 、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大,Abvc Biopharma Inc、Seastar Medical Holding Corp、Transcode Therapeutics Inc较为活跃,换手率分别为190.00%、68.93%、28.22%,振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Eqrx Inc C/Wts 17/12/2026 、Moolec Science Sa C/Wts ,振幅分别为89.24%、83.25%、42.45%。Catalyst Pharmaceuticals Inc公司简介:Catalyst Pharmaceuticals Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102721420282ff9a73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102721420282ff9a73&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.catalystpharma.com","stockEarnings":[{"period":"1week","weight":-0.0409},{"period":"1month","weight":0.1108},{"period":"3month","weight":-0.0518},{"period":"6month","weight":0.3636},{"period":"1year","weight":-0.0467},{"period":"ytd","weight":-0.0518}],"compareEarnings":[{"period":"1week","weight":0.0017},{"period":"1month","weight":0.0318},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.2236},{"period":"1year","weight":0.3033},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Catalyst Pharmaceuticals, Inc.于2006年7月在特拉华州注册成立。该公司是一家商业阶段、以患者为中心的生物制药公司,专注于为患有罕见和难以治疗的疾病的患者提供新的高质量药物的许可、开发和商业化。该公司利用协调一致的勤奋努力,寻找能够改善那些患有罕见或难以治疗的疾病的人的生活的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.053866},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.012194},{"month":3,"riseRate":0.666667,"avgChangeRate":0.104304},{"month":4,"riseRate":0.411765,"avgChangeRate":0.042059},{"month":5,"riseRate":0.529412,"avgChangeRate":-0.039012},{"month":6,"riseRate":0.588235,"avgChangeRate":0.053043},{"month":7,"riseRate":0.588235,"avgChangeRate":0.119007},{"month":8,"riseRate":0.647059,"avgChangeRate":0.238547},{"month":9,"riseRate":0.411765,"avgChangeRate":-0.027434},{"month":10,"riseRate":0.411765,"avgChangeRate":-0.064826},{"month":11,"riseRate":0.529412,"avgChangeRate":0.010396},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.030132}],"exchange":"NASDAQ","name":"Catalyst Pharmaceutical Partners","nameEN":"Catalyst Pharmaceuticals"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Catalyst Pharmaceutical Partners(CPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Catalyst Pharmaceutical Partners(CPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Catalyst Pharmaceutical Partners,CPRX,Catalyst Pharmaceutical Partners股票,Catalyst Pharmaceutical Partners股票老虎,Catalyst Pharmaceutical Partners股票老虎国际,Catalyst Pharmaceutical Partners行情,Catalyst Pharmaceutical Partners股票行情,Catalyst Pharmaceutical Partners股价,Catalyst Pharmaceutical Partners股市,Catalyst Pharmaceutical Partners股票价格,Catalyst Pharmaceutical Partners股票交易,Catalyst Pharmaceutical Partners股票购买,Catalyst Pharmaceutical Partners股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Catalyst Pharmaceutical Partners(CPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Catalyst Pharmaceutical Partners(CPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}